Uspeshnoe primenenie gennoy terapii dlya lecheniya Kh-stseplennoy formy adrenoleykodistrofii

References

[1] Aubourg P., Mandel J.L. X-linked adrenoleukodystrophy. Ann. N. Y. Acad. Sci. 1996; 804: 461-76.

[2] Aubourg P., Dubois-Dalcq M. X-linked adrenoleukodystrophy enigma: how does the ALD peroxisomal transporter mutation affect CNS glia? Glia 2000; 29(2): 186-90.

[3] Shapiro E., Krivit W., Lockman L. et al. Long-term effect of bone-marrow transplantation for childhood-onset cerebral X-linked adrenoleukodystrophy. Lancet 2000; 356(9231): 713-8.

[4] Asheuer M., Pflumio F., Benhamida S. et al. Human CD34+ cells differentiate into microglia and express recombinant therapeutic protein. PNAS 2004; 101(10): 3557-62.

[5] Successful treatment of adrenoleukodystrophy by transplantation of stem cells carrying a new gene therapy vector. INSERM, press information, Friday 06 November 2009.

[6] Schmidt М., Schwarzwaelder К., Bartholomae С. et al. High-resolution insertion-site analysis by linear amplification-mediated PCR (LAM-PCR). Nat. Methods. 2007; 4(12): 1051-7.

[7] Montini E., Cesana D., Schmidt M. et al. The genotoxic potential of retroviral vectors is strongly modulated by vector design and integration site selection in a mouse model of HSC gene therapy. J. Clin. Invest. 2009; 119(4): 964-75.

[8] B. Naldini L. Medicine. A comeback for gene therapy. Science 2009; 326(5954): 805-6.

[9] Breakthrough of the year. The runners-up. Science 2009; 326(5960): 1600-7.

[10] Aiuti A., Cattaneo F., Galimberti S. et al. Gene therapy for immunodeficiency due to adenosine deaminase deficiency. N. Engl. J. Med. 2009; 360(5]; 447-58.

[11] Maguire A., High K., Auricchio A. et al. Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trial. Lancet 2009; 374(9701): 1597-605.

RIGHTS & PERMISSIONS

Eco-Vector